Trial Profile
Non-interventional Study A Multicentre Observational Study for Revaccination With Pollinex Quattro in Patients With a Recurrent Grass Pollen Allergy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2023
Price :
$35
*
At a glance
- Drugs Allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Grass pollen hypersensitivity
- Focus Therapeutic Use
- 27 Oct 2015 New trial record